Podcast: Conversations around interchangeability and biosimilar entries in new therapeutic categories
Launches in ophthalmology and the first interchangeable insulin biosimilar in the U.S. bring new opportunities for this exciting product class. Listen in as our experts discuss these developments.
Continue the conversation
Learn more about our solutions for this important product category.